Accessibility Menu
Genetic Technologies logo

Genetic Technologies(OTC) GNTLF

This security has been delisted. This page is retained for historical reference.

Genetic Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002025-07-25
Genetic Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-100%USD 1.002025-05-05
1 month-100%USD 1.002025-05-05
3 month-100%USD 1.002024-12-27
Year to date-100%USD 1.002024-12-27
1 year-100%USD 0.072023-11-06
3 year-100%USD 1.302022-07-20
5 year-100%USD 0.092020-07-20
Since inception-100%USD 30.002003-07-10

GNTLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

GNTLF Financials

Key Financial Metrics (TTM)

Gross Margin

50.94%

Operating Margin

-159.30%

Net Income Margin

-156.78%

Return on Equity

-184.98%

Return on Capital

-451.29%

Return on Assets

-194.25%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

A$5.24K

Operating Income

-A$14.02M

EBITDA

-A$14.62M

Operating Cash Flow

-A$13.11M

Capital Expenditure

-A$33.25K

Free Cash Flow

-A$12.14M

Cash & ST Invst.

A$1.01M

Total Debt

A$500.00K

Genetic Technologies Performance Analysis

Genetic Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 4,927,540N/A
20232023-06-30AUD 5,842,69918.6%
20242024-06-30AUD 5,022,640-14.0%
Genetic Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-06-309.1%
Q22023-12-31-12.7%
Q42024-06-3021.2%
Q22024-12-31-91.4%
Genetic Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.06N/A
20232023-06-30AUD -0.0839.8%
20242024-06-30AUD -0.06-23.6%
Genetic Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-06-30-15.2%
Q22023-12-3118.4%
Q42024-06-3029.2%
Q22024-12-3143.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

A$413.95K

-90.0%

Gross Profit

A$413.95K

+126.8%

Gross Margin

100.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

55

N/A

Net Income

-A$4.09M

+25.2%

EBITDA

-A$1.33M

+73.7%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

A$1.01M

-79.9%

Total Debt

A$500.00K

-18.4%

Accounts Receivable

A$145.24K

-95.0%

Inventory

A$0.00

-100.0%

Long Term Debt

A$0.00

-100.0%

Short Term Debt

A$500.00K

+76.1%

Return on Assets

-1.94%

N/A

Return on Invested Capital

-6.13%

N/A

Free Cash Flow

-A$78.35K

+97.1%

Operating Cash Flow

-A$71.27K

+97.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRCHFH.U. Group Holdings, Inc.
$23.07+0.52%
TCNNFTrulieve Cannabis Corp.
$11.03+7.61%
EVOTFEvotec SE
$6.69+0.00%
RYHTYRyman Healthcare Limited
$6.11+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.